Status:

COMPLETED

Post-stroke Depression Treatment Effect on Stroke Recurrence

Lead Sponsor:

Ege University

Conditions:

Stroke Recurrence

Cardiovascular Events

Eligibility:

All Genders

Phase:

NA

Brief Summary

It is not clear whether depresssion can predispose, or precipitate stroke recurrence in patients with stroke. We sought the relationship of post stroke depression with stroke recurrence.

Detailed Description

A large body of evidence suggests that depression is associated with a increased risk of many chronic diseases, including hypertension, diabetes, stroke and particularly coronary heart disease. Post s...

Eligibility Criteria

Inclusion

  • • Patients who met DSM-IV and V criteria for depression

Exclusion

  • Severe or unstable medical disorders (eg, myocardial infarction within past 3 months, end-stage cancer, decompensated cardiac failure)
  • Known primary neurological disorders including dementia, delirium, Parkinson disease, brain tumors, multiple sclerosis, seizure disorder
  • Drugs (eg, systemic steroids)
  • Pancreatic cancer, uncorrected hypothyroidism
  • Current suicidal risk
  • Use of psychotropic prescription or nonprescription drugs, certain hypnotics
  • Mini-Mental State Examination (MMSE) score of 21 or lower

Key Trial Info

Start Date :

February 11 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 30 2019

Estimated Enrollment :

1230 Patients enrolled

Trial Details

Trial ID

NCT04776226

Start Date

February 11 2017

End Date

March 30 2019

Last Update

March 1 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ege University

Izmir, Turkey (Türkiye), 35100